Internal Medicine, Infectious Disease · Atlanta, GA
NPI
1760684658
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2140 Peachtree Rd NW Ste 232
Atlanta, GA, 30309
Phone (404) 231-4431
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
390 services
Medicare patients, 2024
33
Average age 65
Drug cost, 2024
$3.8M
2,078 prescriptions
Company payments, 2025
$57K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Quintin R Robinson was code 80053 (clinical chemistry), 54 times for 27 patients. In total Quintin R Robinson billed 390 services in 43 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80053 Clinical Chemistry | Office | 54 | 27 | $10.35 | $559 |
| 87536 Infectious Agent Detection by DNA/RNA | Office | 47 | 20 | $83.40 | $3,920 |
| 85025 Blood Count | Office | 44 | 26 | $7.61 | $335 |
| 84100 Clinical Chemistry | Office | 42 | 19 | $4.65 | $195 |
| 81003 Clinical Chemistry | Office | 28 | 18 | $2.20 | $61.6 |
| 36415 Venipuncture Blood Collection | Office | 18 | 16 | $8.65 | $156 |
By year: 2022 $6,721 for 331 services; 2023 $6,666 for 289 services; 2024 $10K for 390 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 54 | 27 | $10.35 | $559 |
| 87536 Infectious Agent Detection by DNA/RNA | 47 | 20 | $83.40 | $3,920 |
| 85025 Blood Count | 44 | 26 | $7.61 | $335 |
| 84100 Clinical Chemistry | 42 | 19 | $4.65 | $195 |
| 81003 Clinical Chemistry | 28 | 18 | $2.20 | $61.6 |
| 36415 Venipuncture Blood Collection | 18 | 16 | $8.65 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Quintin R Robinson prescribed most often to Medicare patients was Symtuza (Darunavir/Cob/Emtri/Tenof Alaf), with 171 prescriptions and refills. In total Quintin R Robinson wrote 2,078 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 171 | 181 | 18 | $820K |
| Tivicay Dolutegravir Sodium | 120 | 120 | 12 | $308K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 120 | 120 | 12 | $457K |
| Dovato Dolutegravir Sodium/Lamivudine | 98 | 98 | Under 11 | $286K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 76 | 84 | Under 11 | $312K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 74 | 76 | 11 | $286K |
| Valacyclovir Valacyclovir Hcl | 62 | 104 | 13 | $1,999 |
| Amlodipine Besylate Generic | 50 | 94 | 12 | $176 |
| Ritonavir Generic | 46 | 64 | Under 11 | $6,159 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 46 | 62 | Under 11 | $10K |
| Darunavir Generic | 43 | 43 | Under 11 | $30K |
| Isentress Raltegravir Potassium | 43 | 43 | Under 11 | $84K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 39 | 41 | Under 11 | $126K |
| Prezcobix Darunavir/Cobicistat | 38 | 38 | Under 11 | $100K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 36 | 36 | Under 11 | $843 |
Brand drugs: 1,040 claims; generic drugs: - claims; opioid claims: 71.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Quintin R Robinson $57K ($57K in general payments such as food, travel and fees) from 13 companies. The largest payer was ViiV Healthcare Company with $39K.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 82 | $39K |
| Gilead Sciences, Inc. GILD | 48 | $17K |
| Merck Sharp & Dohme LLC MRK | 5 | $108 |
| EMD Serono, Inc. MRK.DE | 4 | $90.46 |
| Novo Nordisk Inc NVO | 5 | $84.21 |
| Theratechnologies Inc. THTX | 4 | $80.56 |
| Verity Pharmaceuticals Inc. | 3 | $47.75 |
| Lilly USA, LLC LLY | 2 | $40.28 |
| Exact Sciences Corporation EXAS | 2 | $30.35 |
| Astellas Pharma US Inc 4503.T | 1 | $27.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.